financetom
Business
financetom
/
Business
/
Tesla Sales in Europe Drop 49% in April
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla Sales in Europe Drop 49% in April
May 27, 2025 5:11 AM

07:52 AM EDT, 05/27/2025 (MT Newswires) -- Tesla's (TSLA) new car sales in Europe dropped 49% in April from a year earlier, while sales from January through April fell 38.8% compared to the same period in 2024, according to data released Tuesday by the European Automobile Manufacturers Association.

Battery-electric vehicle car sales in the region rose 27.8% in April year over year, while overall car sales fell 0.3%, the data showed.

The trade organization records new car registrations in the European Union, UK, and the European Free Trade Association.

Tesla did not immediately reply to a request for comment from MT Newswires.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pelangio Exploration Upsizes Private Placement of Units to $4.5 Million
Pelangio Exploration Upsizes Private Placement of Units to $4.5 Million
Sep 24, 2025
12:59 PM EDT, 09/24/2025 (MT Newswires) -- Pelangio Exploration ( PGXPF ) on Wednesday said it upsized a non-brokered private placement of share units to $4.5 million from $4 million. The units will be priced at $0.18 each and consist of one share and half a two-year warrant to buy a share at $0.31. Proceeds will be used for exploration...
Update: UniQure's Shares Soar After Phase 1/2 Trial in Huntington's Disease Meets Primary Endpoint
Update: UniQure's Shares Soar After Phase 1/2 Trial in Huntington's Disease Meets Primary Endpoint
Sep 24, 2025
01:39 PM EDT, 09/24/2025 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.) UniQure's ( QURE ) shares rose past 234% in recent Wednesday trading after the company said that its phase 1/2 study in Huntington's disease met its primary endpoint, with high-dose AMT-130 showing statistically significant 75% slowing of disease at 36 months as measured...
Update: Cidara's Phase 3 Trial of Influenza Prevention Drug CD388 to Begin in September; Shares Rise
Update: Cidara's Phase 3 Trial of Influenza Prevention Drug CD388 to Begin in September; Shares Rise
Sep 24, 2025
01:38 PM EDT, 09/24/2025 (MT Newswires) -- (Updates with stock price movement in the headline and the first paragraph.) Cidara Therapeutics ( CDTX ) shares rose more than 22% in recent Wednesday trading after the company said it will start enrolling patients for a phase 3 trial of CD388 by the end of September following its end-of-phase 2 meeting with...
Congo sticking to cobalt export quotas, keen to boost processing
Congo sticking to cobalt export quotas, keen to boost processing
Sep 24, 2025
NEW YORK, Sept 24 (Reuters) - Democratic Republic of Congo will stick to its recently announced quota system for cobalt exports, with revisions only possible in the long term if the government sees them as necessary, the country's mining minister said on Wednesday. The mining minister, Louis Watum Kabamba, told Reuters in an interview on the sidelines of a seminar...
Copyright 2023-2025 - www.financetom.com All Rights Reserved